
Elevated Circulating CD19+Lymphocytes Predict Survival Advantage in Patients with Gastric Cancer
Author(s) -
Yu Qian,
Chuan-ding Yu,
ZhiQiang Ling
Publication year - 2012
Publication title -
asian pacific journal of cancer prevention
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.512
H-Index - 75
eISSN - 2476-762X
pISSN - 1513-7368
DOI - 10.7314/apjcp.2012.13.5.2219
Subject(s) - medicine , cd19 , proportional hazards model , hazard ratio , lymphocyte , cd8 , gastroenterology , stage (stratigraphy) , cancer , cohort , retrospective cohort study , oncology , immunology , flow cytometry , antigen , confidence interval , biology , paleontology
Circulating lymphocyte subsets reflect the immunological status and might therefore be a prognostic indicator in cancer patients. Our aim was to evaluate the clinical significance of circulating lymphocyte subset in gastric cancer (GC) cases.